Todd James
Senior Vice President, Corporate Affairs and Investor Relations
Head of Investor Relations
Earnings-call appearances
-
Viridian Therapeutics, Inc.DE Q1 FY2023 Earnings Call2023-05-09
Viridian Therapeutics, Inc.\DE (VRDN)
-
Viridian Therapeutics, Inc.DE Q4 FY2022 Earnings Call2023-03-08
Viridian Therapeutics, Inc.\DE (VRDN)